H-FLPSDFFP^SV^-OH

Ref. 3D-PP48463

Informations sur le produit

• Nom: H-FLPSDFFP^SV^-OH

Description

Peptide H-FLPSDFFP^SV^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLPSDFFP^SV^-OH include the following: An altered peptide ligand for naaca¯ve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity Y Tang, Z Lin, B Ni, J Wei, J Han, H Wang - Cancer Immunology , 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0195-x Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients Y Dou, DTSL Jansen, A van Den Bosch, RA de Man - Antiviral Research, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354219300373 Effects of lamivudine on the hepatitis B virus specific CD8+ cytotoxic T lymphocyte responses via peptide-MHC tetrameric complexes assay TH Lee, YL Chuang, SL Tsai, YF Liaw - Letters in Peptide Science, 2001 - Springerhttps://link.springer.com/article/10.1023/A:1016245617290 Therapeutic polypeptides based on HBcAg18-27 CTL epitope can induce antigen-specific CD8+ CTL-mediated cytotoxicity in HLA-A2 transgenic mice TD Shi, YZ Wu, ZC Jia, W Zhou - World Journal of , 2004 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656366/ Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Development and Validation of a Fluorescence Polarization-Based Competitive Peptide-Binding Assay for HLA-A* 0201 A New Tool for Epitope Discovery R Buchli, RS VanGundy, HD Hickman-Miller - Biochemistry, 2005 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi050255v P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes K Krebs, K Metzger, L Weigand, C Dargel - for ImmunoTherapy of , 2014 - Springerhttps://link.springer.com/article/10.1186/2051-1426-2-S2-P47 Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein JS Bartholomew, SN Stacey, B Coles - European journal of , 1994 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830241239 Viral specific cytotoxic T cells inhibit the growth of TfR-expressing tumor cells with antibody targeted viral peptide/HLA-A2 complex J Li, X Weng, Z Liang, M Zhong, X Chen, S Lu - Cellular , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874910000705 Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments H Li , M Zhou, J Han, X Zhu, T Dong - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/1/195/72240 Identification of two new HLA-A* 0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1 F Liu, H Zhang, D Shen, S Wang, Y Ye, H Chen - Journal of , 2014 - Springerhttps://link.springer.com/article/10.1007/s00535-013-0811-4 Identification of HLA-A2-restricted immunogenic peptides derived from a xenogenic porcine major histocompatibility complex CS Park, SA Im, S Song, K Kim, CK Lee - Xenotransplantation, 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/xen.12119 Use of Protein Modeling to Evaluate Human Leukocyte Antigen-Peptide Binding Interactions with the Multiple Myeloma HM1. 24 Antigen CN Johnson - 2014 - search.proquest.comhttps://search.proquest.com/openview/922d2f5269b103d4dba7711ad1ad0dbd/1?pq-origsite=gscholar&cbl=18750

• Marque: Biosynth